Operating Income Summary of Abbott India Limited

Abbott India Limited's latest annual operating income in 2023 was 13.79 Billion INR , up 7.14% from previous year.
Abbott India Limited's latest quarterly operating income in 2024 Q1 was 3.72 Billion INR , up 19.69% from previous quarter.
Abbott India Limited reported an annual operating income of 12.89 Billion INR in 2022, up 17.31% from previous year.
Abbott India Limited reported an annual operating income of 10.99 Billion INR in 2021, up 15.82% from previous year.
Abbott India Limited reported a quarterly operating income of 3.11 Billion INR for 2023 Q4, down -26.8% from previous quarter.
Abbott India Limited reported a quarterly operating income of 3.93 Billion INR for 2023 Q1, up 26.06% from previous quarter.

Annual Operating Income Chart of Abbott India Limited (2023 - 2004)

Historical Annual Operating Income of Abbott India Limited (2023 - 2004)

Year	Operating Income	Operating Income Growth
2023	13.79 Billion INR	7.14%
2022	12.89 Billion INR	17.31%
2021	10.99 Billion INR	15.82%
2020	9.49 Billion INR	17.0%
2019	8.11 Billion INR	37.23%
2018	5.91 Billion INR	14.98%
2017	5.14 Billion INR	33.83%
2016	3.84 Billion INR	8.14%
2015	3.55 Billion INR	16.23%
2014	3.05 Billion INR	42.04%
2013	2.15 Billion INR	27.37%
2012	1.68 Billion INR	-16.27%
2011	2.01 Billion INR	127.26%
2010	888.03 Million INR	-20.7%
2009	1.11 Billion INR	27.19%
2008	880.5 Million INR	-11.73%
2007	997.5 Million INR	14.76%
2006	869.2 Million INR	-0.14%
2005	870.4 Million INR	-37.02%
2004	1.38 Billion INR	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	3.72 Billion INR	19.69%
2023 Q4	3.11 Billion INR	-26.8%
2023 Q1	3.93 Billion INR	26.06%
2023 FY	13.81 Billion INR	7.14%
2023 Q2	4.18 Billion INR	6.28%
2023 Q3	4.25 Billion INR	1.62%
2022 FY	12.89 Billion INR	17.31%
2022 Q3	3.38 Billion INR	-5.77%
2022 Q4	3.12 Billion INR	-7.74%
2022 Q1	2.79 Billion INR	-6.06%
2022 Q2	3.59 Billion INR	28.61%
2021 Q4	2.97 Billion INR	9.73%
2021 FY	10.99 Billion INR	15.82%
2021 Q1	2.49 Billion INR	25.15%
2021 Q2	2.43 Billion INR	-2.38%
2021 Q3	2.71 Billion INR	11.32%
2020 Q1	2.19 Billion INR	66.22%
2020 Q4	1.99 Billion INR	-12.27%
2020 FY	9.49 Billion INR	17.0%
2020 Q3	2.27 Billion INR	0.34%
2020 Q2	2.26 Billion INR	3.24%
2019 Q3	2.24 Billion INR	18.75%
2019 FY	8.11 Billion INR	37.23%
2019 Q1	1.59 Billion INR	5.22%
2019 Q2	1.89 Billion INR	18.7%
2019 Q4	1.31 Billion INR	-41.27%
2018 FY	5.91 Billion INR	14.98%
2018 Q4	1.51 Billion INR	6.27%
2018 Q3	1.42 Billion INR	-24.96%
2018 Q2	1.89 Billion INR	76.93%
2018 Q1	1.07 Billion INR	4.58%
2017 Q4	1.02 Billion INR	-35.48%
2017 Q3	1.59 Billion INR	-19.35%
2017 Q2	1.97 Billion INR	242.12%
2017 Q1	576.7 Million INR	-2.3%
2017 FY	5.14 Billion INR	33.83%
2016 FY	3.84 Billion INR	8.14%
2016 Q2	1.01 Billion INR	0.66%
2016 Q4	590.3 Million INR	-50.27%
2016 Q3	1.18 Billion INR	16.49%
2016 Q1	1.01 Billion INR	26.31%
2015 Q3	986.1 Million INR	19.01%
2015 Q4	801.5 Million INR	-18.72%
2015 Q1	924.3 Million INR	26.07%
2015 FY	3.55 Billion INR	16.23%
2015 Q2	828.6 Million INR	-10.35%
2014 Q2	835.8 Million INR	25.5%
2014 Q1	666 Million INR	18.25%
2014 FY	3.05 Billion INR	42.04%
2014 Q3	822.1 Million INR	-1.64%
2014 Q4	733.18 Million INR	-10.82%
2013 FY	2.15 Billion INR	27.37%
2013 Q3	599.9 Million INR	-2.03%
2013 Q2	612.3 Million INR	62.41%
2013 Q1	377 Million INR	-7.33%
2013 Q4	563.19 Million INR	-6.12%
2012 Q3	379.22 Million INR	-32.39%
2012 Q1	404 Million INR	750.53%
2012 FY	1.68 Billion INR	-16.27%
2012 Q2	560.9 Million INR	38.84%
2012 Q4	406.8 Million INR	7.27%
2011 Q4	47.5 Million INR	-93.88%
2011 Q3	775.58 Million INR	19.89%
2011 Q2	646.9 Million INR	0.0%
2011 FY	2.01 Billion INR	127.26%
2010 FY	888.03 Million INR	-20.7%
2009 FY	1.11 Billion INR	27.19%
2008 FY	880.5 Million INR	-11.73%
2007 FY	997.5 Million INR	14.76%
2006 FY	869.2 Million INR	-0.14%
2005 FY	870.4 Million INR	-37.02%
2004 FY	1.38 Billion INR	0.0%

Peer Operating Income Comparison of Abbott India Limited

Name	Operating Income	Operating Income Difference
Cipla Limited	105.7 Billion INR	86.951%
Gland Pharma Limited	9.9 Billion INR	-39.23%
GlaxoSmithKline Pharmaceuticals Limited	13.6 Billion INR	-1.411%
Kopran Limited	615.26 Million INR	-2141.964%
Marksans Pharma Limited	7.79 Billion INR	-77.037%
NGL Fine-Chem Limited	416.27 Million INR	-3213.707%
Pfizer Limited	9.61 Billion INR	-43.513%
Sanofi India Limited	7.79 Billion INR	-76.869%
SMS Pharmaceuticals Limited	833.64 Million INR	-1554.663%

Global Stocks Search

Abbott India Limited (ABBOTINDIA.BO)

Operating Income Summary of Abbott India Limited

Annual Operating Income Chart of Abbott India Limited (2023 - 2004)

Historical Annual Operating Income of Abbott India Limited (2023 - 2004)

Peer Operating Income Comparison of Abbott India Limited